02403oas 2200433z 450 99626704860331620221206094724.0(OCoLC)947097018(CKB)3710000000614179(DE-599)ZDB2865010-4(NjHacI)993710000000614179(EXLCZ)99371000000061417920170808a20169999 sy aengurmnu---|||||txtrdacontentcrdamediacrrdacarrierJACCBasic to translational science[New York] :Elsevier on behalf of the American College of Cardiology Foundation,[2016]-1 online resourceRefereed/Peer-reviewed2452-302X Introducing JACC: Basic to Translational Science: Why Now? -- Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning -- Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation -- Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model -- Telomerase Inhibition by Everolimus Suppresses Smooth Muscle Cell Proliferation and Neointima Formation Through Epigenetic Gene Silencing -- The Role of the L-Type Ca2+ Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic CardiomyopathyCell Therapy for Heart Failure With Preserved Ejection Fraction -- Better Blood Flow Delivered: Extracellular Matrix-Derived Hydrogels for the Induction of Arteriogenesis in Peripheral Artery Disease? -- Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group -- Broadview Ventures: Investing in the Future of Cardiovascular Technology.Clinical medicineResearchMedicine, ExperimentalTranslational Research, BiomedicalPeriodical.Clinical medicineResearch.Medicine, Experimental.Translational Research, Biomedical.610.72American College of Cardiology,NjHacINjHacIJOURNAL996267048603316JACC1893990UNISA